To recover your password please fill in your email address
Please fill in below form to create an account with us
HYNOVA is a randomized clinical trial comparing the effects of chemotherapy drug given into the abdominal cavity at a temperature of 42°C (heated, HIPEC) versus 37°C (body temperature, NIPEC) at the end of surgery in patients with advanced cancer of the ovary, fallopian tube or peritoneum.
|
Trial Summary: |
HYNOVA is a randomized clinical trial comparing the effects of chemotherapy drug given into the abdominal cavity at a temperature of 42°C (heated, HIPEC) versus 37°C (body temperature, NIPEC) at the end of surgery in patients with advanced cancer of the ovary, fallopian tube or peritoneum. |
|
Supported By: |
The University of Sydney, Australia New Zealand Gynaecological Oncology Group |
|
Eligibility: |
Patients with histologically or cytologically confirmed stage III epithelial OTP cancer following neoadjuvant chemotherapy with at least stable disease, undergoing interval CRS with residual disease of <2.5mm. |
|
Registration ID: |
ACTRN12621000269831 |
|
Participation: |
Australia |
|
Australian Lead Group: |
Australia New Zealand Gynaecological Oncology Group |
|
Status: |
Recruiting |
|
Activation Date: |
September 2021 |
|
Chairs: |
A/Prof Rhonda Farrell |
|
Contact: |